Computer-Assisted Hair Restoration Study Using ARTAS System
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05938569 |
Recruitment Status :
Recruiting
First Posted : July 10, 2023
Last Update Posted : July 10, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Androgenic Alopecia | Device: Hair restoration | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Computer-Assisted Hair Restoration Study Using ARTAS System |
Study Start Date : | November 3, 2016 |
Estimated Primary Completion Date : | December 30, 2024 |
Estimated Study Completion Date : | December 30, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: All subjects
The Study Treatment will involve follicular hair unit harvest, recipient site making, and implantation.
|
Device: Hair restoration
The Study Treatment will involve follicular hair unit harvest, recipient site making, and implantation. |
- Change in Hair Density from pre to 12 months post-treatment in robotic vs manual implantation [ Time Frame: 1 year post-treatment ]
- Percentage of follicles successfully harvested by Robot [ Time Frame: 1 year post-treatment ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subject is male with clinical diagnosis of androgenetic alopecia with Norwood-Hamilton grade of III-VI
- Subject is 20 to 70 years old
- Subject agrees to cut hair short (< 1 mm) on the scalp in the designated study areas for harvesting and implantation
- Subject is able to understand and provide written consent
- Subject consents to post-operative follow-up per protocol
Exclusion Criteria:
- Subject has prior history of scalp reduction surgery(s) in the past six months
- Subject has bleeding diathesis
- Subject has active use of anti-coagulation medication
- Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05938569
Contact: Director of Clinical Affairs, PhD | 8889070115 | mgronski@venusconcept.com |
United States, California | |
Berman Skin Institute | Recruiting |
Los Altos, California, United States, 94022 | |
Contact: David Berman, M.D. 650-325-6000 david.berman@skinmds.com | |
Contact: Anna Marte (650) 325-6000 anna.marte@skinmds.com | |
Principal Investigator: David Berman, M.D. | |
Le's Aesthetics | Recruiting |
San Jose, California, United States, 95112 | |
Contact: Vincent Le, D.O. 408-835-9977 vle02@yahoo.com | |
Contact: Lin Phong 408-835-9977 infohaircenters@gmail.com | |
Principal Investigator: Vincent Le |
Responsible Party: | Venus Concept |
ClinicalTrials.gov Identifier: | NCT05938569 |
Other Study ID Numbers: |
CP-017 |
First Posted: | July 10, 2023 Key Record Dates |
Last Update Posted: | July 10, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | Yes |
Alopecia Hypotrichosis Hair Diseases Skin Diseases Pathological Conditions, Anatomical |